30 results about "Preventing initiation" patented technology

A high density animal housing system with an air source conduit and an air exhaust conduit is normally coupled to one or more ventilating animal cage racks through standard inlet / outlet fittings. A euthanasia fixture is coupled into the standard inlet / outlet fittings and selectively and sequentially operates valves and / or blowers to switch from supply of respiration air to a gas supply, to open and close the flow to the exhaust and to resume ventilation afterwards, for venting. The sequence is timed and controlled by a programmable controller that activates the associated blowers and valves automatically to follow a user selected sequence. The system anesthetizes and then euthanizes the animals via the same flow conduits that otherwise supply respiration air, requiring no rack modifications and little if any human attention other than to couple the rack to the ventilation system at the euthanasia fixture. Operator inputs allow selection among sequences. Status sensing inputs prevent initiation or continuation of a cycle in the event of certain faults.

A portable communication device is equipped with keypad filter circuitry, which is operable to eliminate or otherwise minimize calls, such as emergency calls and non-emergency calls, due to accidental or unintentional key press sequences. The keypad filter circuitry receives keypad input, analyzes the received keypad input and determines if the keypad input is accidental or unintentional. If the keypad input is determined to be accidental or unintentional, the portable communication device takes action to prevent initiation of the call and / or unlocking of the keypad.

A method of preventing initiation of an explosive device. The method comprises substantially encasing an explosive device with a conductive foam. The explosive device is configured to be initiated by an electromagnetic radiation signal, such as that emitted by a transmitter of a wireless door bell device. Deactivated explosive devices are also disclosed.

A clear ice maker unit has a clear ice maker mechanism with a cascading water evaporator configured to make clear ice during ice making cycles. A controller uses fuzzy logic to control the clear ice maker and determine whether to initiate a next ice making cycle based on input signals from a thermistor in the ice storage bin. The controller will prevent initiation of an ice making cycle when the ice bin is at or below a threshold temperature. The controller will also prohibit ice making when the ice bin is at or below a second, slightly higher temperature for more than a prescribed period of time. In this way, the clear ice maker can recognize an uneven distribution of ice and maintain an optimal amount of ice in the bin.

A method, a system, and a computer program product for preventing initiation of a voice recognition session. The method includes monitoring at least one audio output channel for at least one audio trigger phrase that initiates a voice recognition session. The method further includes in response to detecting the at least one audio trigger phrase on the at least one audio output channel, setting a logic state of at least one output trigger detector of the at least one audio output channel to a first state. The method further includes gating a logic state of at least one input trigger detector of at least one audio input channel to the first state for a time period and preventing initiation of a voice recognition session by the at least one audio trigger phrase on the at least one audio input channel while the logic state is the first state.

A method for protecting Ethernet data packets transmitted over SDH / SONET traffic in a ring-like optical network formed by a number of nodes, the method includes utilizing MS-SPRING / BLSR system for SDH / SONET traffic protection and, in case of one or more network failures that result in at least one isolated node in the network, the method comprises preventing initiation of a squelching algorithm of the MS-SPRING / BLSR system with respect to the SDH / SONET virtual containers carrying the data Ethernet packets, while ensuring that the standardized use of byte J1 is prevented with respect to the same SDH / SONET virtual containers carrying the Ethernet packets.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

A method of preventing initiation of an explosive device. The method comprises substantially encasing an explosive device with a conductive foam. The explosive device is configured to be initiated by an electromagnetic radiation signal, such as that emitted by a transmitter of a wireless door bell device. Deactivated explosive devices are also disclosed.

An initiator including a housing adapted to be received in an igniter or rocket motor, at least one charge at a distal end of the housing, an electro-explosive device behind the charge for detonating the charge when subject to a voltage HV, and a pressure bulkhead behind the electro-explosive device. An electronic subsystem in the housing is connected to the electro-explosive device through the bulkhead and includes a lead for providing the voltage HV to the electro-explosive device to initiate it, and a switch in the lead which does not conduct if errant voltages are present on the lead to prevent initiation of the electro-explosive device until the correct voltage HV is present.

A method of producing a propellant material element, such as an electrically-operated propellant material, includes extruding a propellant material through a heated nozzle. The nozzle may be heated to a temperature that is above the boiling point of a solvent that is part of the propellant material, yet is below a decomposition temperature of the propellant material. This allows some of the solvent to be driven off during the extruding process, while still preventing initiation of an energy-creating reaction within the material. The heating of the material in the extruding process, and especially the heating of the nozzle that the material is extruded through, may be controlled to remove an amount of solvent that results in the extruded material having desirable properties.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides small heat shock protein activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease.

A method of producing a propellant material element, such as an electrically-operated propellant material, includes extruding a propellant material through a heated nozzle. The nozzle may be heated to a temperature that is above the boiling point of a solvent that is part of the propellant material, yet is below a decomposition temperature of the propellant material. This allows some of the solvent to be driven off during the extruding process, while still preventing initiation of an energy-creating reaction within the material. The heating of the material in the extruding process, and especially the heating of the nozzle that the material is extruded through, may be controlled to remove an amount of solvent that results in the extruded material having desirable properties.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

A method for protecting Ethernet data packets transmitted over SDH / SONET traffic in a ring-like optical network formed by a number of nodes, the method includes utilizing MS-SPRING / BLSR system for SDH / SONET traffic protection and, in case of one or more network failures that result in at least one isolated node in the network, the method comprises preventing initiation of a squelching algorithm of the MS-SPRING / BLSR system with respect to the SDH / SONET virtual containers carrying the data Ethernet packets, while ensuring that the standardized use of byte J1 is prevented with respect to the same SDH / SONET virtual containers carrying the Ethernet packets.

An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of specific peptides derived from HSPB5, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

Techniques for determining appropriate locations to update mobile device software to prevent initiation of unwanted software updates are provided. An example method includes identifying one or more wireless access points within wireless connection range of a mobile device, determining whether a wireless access point of the one or more identified wireless access points is included in a list of preferred wireless access points, the list generated with consideration to previous software updates performed via the preferred wireless access points and durations of network connectivity during the previous software updates, scheduling one or more software updates using the wireless access point, when the wireless access point is included in the list of preferred wireless access points, and performing the scheduled software updates upon connection to the wireless access point.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an amyloid beta peptide, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease.

An initiator including a housing adapted to be received in an igniter or rocket motor, at least one charge at a distal end of the housing, an electro-explosive device behind the charge for detonating the charge when subject to a voltage HV, and a pressure bulkhead behind the electro-explosive device. An electronic subsystem in the housing is connected to the electro-explosive device through the bulkhead and includes a lead for providing the voltage HV to the electro-explosive device to initiate it, and a switch in the lead which does not conduct if errant voltages are present on the lead to prevent initiation of the electro-explosive device until the correct voltage HV is present.

The present disclosure relates generally to a computing device, a method implemented on the computing device, and a non-transient computer-readable storage medium that stores computer-readable instructions that, when executed, cause a processor of the computing device to execute the method. The computing device includes one or more input devices for providing user input on the computing device; and a processor operatively coupled to the one or more input devices and configured to execute the method. The method includes detecting an initiating first user input on a computing device for requesting an operation, the operation initially being in a locked state; detecting a second user input on the computing device, the second user input comprising a number of input steps via a first input device coupled to the computing device; if the second user input does not correspond to the predefined mode, maintaining the operation in a locked state, the locked state preventing initiation of the operation; Transitioning an operation from a locked state to an unlocked state if the second user input corresponds to a predefined mode; And initiating an operation on the computing device in response tothe operation being in an unlocked state.

A portable communication device (10) is equipped with keypad filter circuitry (38), which is operable to eliminate or otherwise minimize calls, such as emergency calls and non-emergency calls, due to accidental or unintentional key press sequences. The keypad filter circuitry (38) receives (100) keypad input, analyzes (105) the received keypad input and determines (110) if the keypad input is accidental or unintentional. If the keypad input is determined to be accidental or unintentional, the portable communication device takes action to prevent initiation of the call and / or unlocking of the keypad.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an amyloid beta peptide, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease.

An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.